Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Status and Forecast 2020-2026

May 2020 | 131 pages | ID: G1D2179B31C8EN
QYResearch

Abstracts

This report focuses on the global Circulating Tumor Cell (CTC) Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cell (CTC) Diagnostics development in North America, Europe, China, Japan, SoutheastAsia, India and Central& South America.

The key players covered in this study

• ApoCell, Inc.(US)
• Biocep Ltd. (Israel)
• Biocept, Inc.(US)
• Biofluidica MicrotechnologiesLLc(US)
• Celltraffix Inc.(US)
• ClearbridgeBiomedics(Singapore)
• Creatv Microtech, Inc.(US)
• CynvenioBiosystems, Inc.(US)
• EpicBiosciencesInc.(US)
• FluxionBiosciences, Inc.(US)
• Ikonisys, Inc.(US)
• IVDiagnostics, Inc.(US)
• JanssenDiagnosticsLLc(US)
• QIAGEnHannoverGmbH (Germany)
• RARECELLsSAs(Italy)
• ScreenCell(France)
• STEMCELlTechnologies, Inc.(Canada)

Market segment by Type, the product can be split into

• CTC Enrichment
• CTC Detection

Market segment by Application, split into

• Hospitals and clinics
• Pharmaceuticals and biotechnology companies
• Academic research institutes
• CROs

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• SoutheastAsia
• India
• Central& South America

The study objectives of this report are:

• To analyze global Circulating Tumor Cell (CTC) Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the Circulating Tumor Cell (CTC) Diagnostics development in North America, Europe, China, Japan, SoutheastAsia, India and Central& South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Circulating Tumor Cell (CTC) Diagnostics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CTC Enrichment
  1.4.3 CTC Detection
1.5 Market by Application
  1.5.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and clinics
  1.5.3 Pharmaceuticals and biotechnology companies
  1.5.4 Academic research institutes
  1.5.5 CROs
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2015-2026)
2.2 Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Regions
  2.2.1 Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Share by Regions (2015-2020)
  2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Circulating Tumor Cell (CTC) Diagnostics Market Growth Strategy
  2.3.6 Primary Interviews with Key Circulating Tumor Cell (CTC) Diagnostics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Market Size
  3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2015-2020)
  3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
  3.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2019
3.3 Circulating Tumor Cell (CTC) Diagnostics Key Players Head office and Area Served
3.4 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
3.5 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2021-2026)

5 CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
6.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in North America (2019-2020)
6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
7.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
8.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in China (2019-2020)
8.3 China Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
8.4 China Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
9.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
9.4 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

10 SOUTHEASTASIA

10.1 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
10.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in SoutheastAsia (2019-2020)
10.3 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
10.4 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

11 INDIA

11.1 India Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
11.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in India (2019-2020)
11.3 India Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
11.4 India Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

12 CENTRAL& SOUTH AMERICA

12.1 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
12.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Central& South America (2019-2020)
12.3 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
12.4 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 ApoCell, Inc.(US)
  13.1.1 ApoCell, Inc.(US) Company Details
  13.1.2 ApoCell, Inc.(US) Business Overview and Its Total Revenue
  13.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020))
  13.1.5 ApoCell, Inc.(US) Recent Development
13.2 Biocep Ltd. (Israel)
  13.2.1 Biocep Ltd. (Israel) Company Details
  13.2.2 Biocep Ltd. (Israel) Business Overview and Its Total Revenue
  13.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.2.5 Biocep Ltd. (Israel) Recent Development
13.3 Biocept, Inc.(US)
  13.3.1 Biocept, Inc.(US) Company Details
  13.3.2 Biocept, Inc.(US) Business Overview and Its Total Revenue
  13.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.3.5 Biocept, Inc.(US) Recent Development
13.4 Biofluidica MicrotechnologiesLLc(US)
  13.4.1 Biofluidica MicrotechnologiesLLc(US) Company Details
  13.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview and Its Total Revenue
  13.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
13.5 Celltraffix Inc.(US)
  13.5.1 Celltraffix Inc.(US) Company Details
  13.5.2 Celltraffix Inc.(US) Business Overview and Its Total Revenue
  13.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.5.5 Celltraffix Inc.(US) Recent Development
13.6 ClearbridgeBiomedics(Singapore)
  13.6.1 ClearbridgeBiomedics(Singapore) Company Details
  13.6.2 ClearbridgeBiomedics(Singapore) Business Overview and Its Total Revenue
  13.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.6.5 ClearbridgeBiomedics(Singapore) Recent Development
13.7 Creatv Microtech, Inc.(US)
  13.7.1 Creatv Microtech, Inc.(US) Company Details
  13.7.2 Creatv Microtech, Inc.(US) Business Overview and Its Total Revenue
  13.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.7.5 Creatv Microtech, Inc.(US) Recent Development
13.8 CynvenioBiosystems, Inc.(US)
  13.8.1 CynvenioBiosystems, Inc.(US) Company Details
  13.8.2 CynvenioBiosystems, Inc.(US) Business Overview and Its Total Revenue
  13.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.8.5 CynvenioBiosystems, Inc.(US) Recent Development
13.9 EpicBiosciencesInc.(US)
  13.9.1 EpicBiosciencesInc.(US) Company Details
  13.9.2 EpicBiosciencesInc.(US) Business Overview and Its Total Revenue
  13.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.9.5 EpicBiosciencesInc.(US) Recent Development
13.10 FluxionBiosciences, Inc.(US)
  13.10.1 FluxionBiosciences, Inc.(US) Company Details
  13.10.2 FluxionBiosciences, Inc.(US) Business Overview and Its Total Revenue
  13.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  13.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  13.10.5 FluxionBiosciences, Inc.(US) Recent Development
13.11 Ikonisys, Inc.(US)
  10.11.1 Ikonisys, Inc.(US) Company Details
  10.11.2 Ikonisys, Inc.(US) Business Overview and Its Total Revenue
  10.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  10.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  10.11.5 Ikonisys, Inc.(US) Recent Development
13.12 IVDiagnostics, Inc.(US)
  10.12.1 IVDiagnostics, Inc.(US) Company Details
  10.12.2 IVDiagnostics, Inc.(US) Business Overview and Its Total Revenue
  10.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  10.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  10.12.5 IVDiagnostics, Inc.(US) Recent Development
13.13 JanssenDiagnosticsLLc(US)
  10.13.1 JanssenDiagnosticsLLc(US) Company Details
  10.13.2 JanssenDiagnosticsLLc(US) Business Overview and Its Total Revenue
  10.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  10.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  10.13.5 JanssenDiagnosticsLLc(US) Recent Development
13.14 QIAGEnHannoverGmbH (Germany)
  10.14.1 QIAGEnHannoverGmbH (Germany) Company Details
  10.14.2 QIAGEnHannoverGmbH (Germany) Business Overview and Its Total Revenue
  10.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
  10.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  10.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
13.15 RARECELLsSAs(Italy)
  10.15.1 RARECELLsSAs(Italy) Company Details
  10.15.2 RARECELLsSAs(Italy) Business Overview and Its Total Revenue
  10.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
  10.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  10.15.5 RARECELLsSAs(Italy) Recent Development
13.16 ScreenCell(France)
  10.16.1 ScreenCell(France) Company Details
  10.16.2 ScreenCell(France) Business Overview and Its Total Revenue
  10.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
  10.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  10.16.5 ScreenCell(France) Recent Development
13.17 STEMCELlTechnologies, Inc.(Canada)
  10.17.1 STEMCELlTechnologies, Inc.(Canada) Company Details
  10.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview and Its Total Revenue
  10.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
  10.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  10.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Circulating Tumor Cell (CTC) Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
Table 3. Ranking of Global Top Circulating Tumor Cell (CTC) Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CTC Enrichment
Table 6. Key Players of CTC Detection
Table 7. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Circulating Tumor Cell (CTC) Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Circulating Tumor Cell (CTC) Diagnostics Players
Table 18. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2019)
Table 21. Global Circulating Tumor Cell (CTC) Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
Table 24. Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Circulating Tumor Cell (CTC) Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Circulating Tumor Cell (CTC) Diagnostics Market Share (2019-2020)
Table 34. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 36. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Circulating Tumor Cell (CTC) Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Circulating Tumor Cell (CTC) Diagnostics Market Share (2019-2020)
Table 40. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Circulating Tumor Cell (CTC) Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Circulating Tumor Cell (CTC) Diagnostics Market Share (2019-2020)
Table 46. China Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 48. China Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Circulating Tumor Cell (CTC) Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Circulating Tumor Cell (CTC) Diagnostics Market Share (2019-2020)
Table 52. Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 56. SoutheastAsia Key Players Circulating Tumor Cell (CTC) Diagnostics Revenue (2019-2020) (Million US$)
Table 57. SoutheastAsia Key Players Circulating Tumor Cell (CTC) Diagnostics Market Share (2019-2020)
Table 58. SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 60. SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Circulating Tumor Cell (CTC) Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Circulating Tumor Cell (CTC) Diagnostics Market Share (2019-2020)
Table 64. India Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 66. India Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 68. Central& South America Key Players Circulating Tumor Cell (CTC) Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central& South America Key Players Circulating Tumor Cell (CTC) Diagnostics Market Share (2019-2020)
Table 70. Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 72. Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 74. ApoCell, Inc.(US) Company Details
Table 75. ApoCell, Inc.(US) Business Overview
Table 76. ApoCell, Inc.(US) Product
Table 77. ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 78. ApoCell, Inc.(US) Recent Development
Table 79. Biocep Ltd. (Israel) Company Details
Table 80. Biocep Ltd. (Israel) Business Overview
Table 81. Biocep Ltd. (Israel) Product
Table 82. Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 83. Biocep Ltd. (Israel) Recent Development
Table 84. Biocept, Inc.(US) Company Details
Table 85. Biocept, Inc.(US) Business Overview
Table 86. Biocept, Inc.(US) Product
Table 87. Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 88. Biocept, Inc.(US) Recent Development
Table 89. Biofluidica MicrotechnologiesLLc(US) Company Details
Table 90. Biofluidica MicrotechnologiesLLc(US) Business Overview
Table 91. Biofluidica MicrotechnologiesLLc(US) Product
Table 92. Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 93. Biofluidica MicrotechnologiesLLc(US) Recent Development
Table 94. Celltraffix Inc.(US) Company Details
Table 95. Celltraffix Inc.(US) Business Overview
Table 96. Celltraffix Inc.(US) Product
Table 97. Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 98. Celltraffix Inc.(US) Recent Development
Table 99. ClearbridgeBiomedics(Singapore) Company Details
Table 100. ClearbridgeBiomedics(Singapore) Business Overview
Table 101. ClearbridgeBiomedics(Singapore) Product
Table 102. ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 103. ClearbridgeBiomedics(Singapore) Recent Development
Table 104. Creatv Microtech, Inc.(US) Company Details
Table 105. Creatv Microtech, Inc.(US) Business Overview
Table 106. Creatv Microtech, Inc.(US) Product
Table 107. Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 108. Creatv Microtech, Inc.(US) Recent Development
Table 109. CynvenioBiosystems, Inc.(US) Business Overview
Table 110. CynvenioBiosystems, Inc.(US) Product
Table 111. CynvenioBiosystems, Inc.(US) Company Details
Table 112. CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 113. CynvenioBiosystems, Inc.(US) Recent Development
Table 114. EpicBiosciencesInc.(US) Company Details
Table 115. EpicBiosciencesInc.(US) Business Overview
Table 116. EpicBiosciencesInc.(US) Product
Table 117. EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 118. EpicBiosciencesInc.(US) Recent Development
Table 119. FluxionBiosciences, Inc.(US) Company Details
Table 120. FluxionBiosciences, Inc.(US) Business Overview
Table 121. FluxionBiosciences, Inc.(US) Product
Table 122. FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 123. FluxionBiosciences, Inc.(US) Recent Development
Table 124. Ikonisys, Inc.(US) Company Details
Table 125. Ikonisys, Inc.(US) Business Overview
Table 126. Ikonisys, Inc.(US) Product
Table 127. Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 128. Ikonisys, Inc.(US) Recent Development
Table 129. IVDiagnostics, Inc.(US) Company Details
Table 130. IVDiagnostics, Inc.(US) Business Overview
Table 131. IVDiagnostics, Inc.(US) Product
Table 132. IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 133. IVDiagnostics, Inc.(US) Recent Development
Table 134. JanssenDiagnosticsLLc(US) Company Details
Table 135. JanssenDiagnosticsLLc(US) Business Overview
Table 136. JanssenDiagnosticsLLc(US) Product
Table 137. JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 138. JanssenDiagnosticsLLc(US) Recent Development
Table 139. QIAGEnHannoverGmbH (Germany) Company Details
Table 140. QIAGEnHannoverGmbH (Germany) Business Overview
Table 141. QIAGEnHannoverGmbH (Germany) Product
Table 142. QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 143. QIAGEnHannoverGmbH (Germany) Recent Development
Table 144. RARECELLsSAs(Italy) Company Details
Table 145. RARECELLsSAs(Italy) Business Overview
Table 146. RARECELLsSAs(Italy) Product
Table 147. RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 148. RARECELLsSAs(Italy) Recent Development
Table 149. ScreenCell(France) Company Details
Table 150. ScreenCell(France) Business Overview
Table 151. ScreenCell(France) Product
Table 152. ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 153. ScreenCell(France) Recent Development
Table 154. STEMCELlTechnologies, Inc.(Canada) Company Details
Table 155. STEMCELlTechnologies, Inc.(Canada) Business Overview
Table 156. STEMCELlTechnologies, Inc.(Canada) Product
Table 157. STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (Million US$)
Table 158. STEMCELlTechnologies, Inc.(Canada) Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and clinics Case Studies
Figure 6. Pharmaceuticals and biotechnology companies Case Studies
Figure 7. Academic research institutes Case Studies
Figure 8. CROs Case Studies
Figure 9. Circulating Tumor Cell (CTC) Diagnostics Report Years Considered
Figure 10. Global Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions: 2020 VS 2026
Figure 12. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players in 2019
Figure 15. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2019
Figure 17. North America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. ApoCell, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. ApoCell, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 26. Biocep Ltd. (Israel) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Biocep Ltd. (Israel) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 28. Biocept, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Biocept, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 30. Biofluidica MicrotechnologiesLLc(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Biofluidica MicrotechnologiesLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 32. Celltraffix Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Celltraffix Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 34. ClearbridgeBiomedics(Singapore) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. ClearbridgeBiomedics(Singapore) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 36. Creatv Microtech, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Creatv Microtech, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 38. CynvenioBiosystems, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. CynvenioBiosystems, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 40. EpicBiosciencesInc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. EpicBiosciencesInc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 42. FluxionBiosciences, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. FluxionBiosciences, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 44. Ikonisys, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Ikonisys, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 46. IVDiagnostics, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. IVDiagnostics, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 48. JanssenDiagnosticsLLc(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. JanssenDiagnosticsLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 50. QIAGEnHannoverGmbH (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. QIAGEnHannoverGmbH (Germany) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 52. RARECELLsSAs(Italy) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. RARECELLsSAs(Italy) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 54. ScreenCell(France) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. ScreenCell(France) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 56. STEMCELlTechnologies, Inc.(Canada) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. STEMCELlTechnologies, Inc.(Canada) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed